Pfizer Inc (PFE)

35.84 -0.32  -0.88% NYSE Jun 3, 12:27 Delayed 2m USD

Pfizer Revenue (TTM):

50.66B for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Revenue (TTM) Chart

Export Data
Save Image
Print Image

Historical Revenue (TTM) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 50.66B
Dec. 31, 2019 51.75B
Sept. 30, 2019 53.04B
June 30, 2019 53.66B
March 31, 2019 53.86B
Dec. 31, 2018 53.65B
Sept. 30, 2018 53.37B
June 30, 2018 53.24B
March 31, 2018 52.67B
Dec. 31, 2017 52.55B
Sept. 30, 2017 52.47B
June 30, 2017 52.35B
March 31, 2017 52.60B
Dec. 31, 2016 52.82B
Sept. 30, 2016 53.24B
June 30, 2016 52.29B
March 31, 2016 50.99B
Dec. 31, 2015 48.85B
Sept. 30, 2015 47.92B
June 30, 2015 48.20B
March 31, 2015 49.12B
Dec. 31, 2014 49.60B
Sept. 30, 2014 50.04B
June 30, 2014 50.33B
March 31, 2014 50.53B
   
Dec. 31, 2013 51.58B
Sept. 30, 2013 51.92B
June 30, 2013 52.23B
March 31, 2013 53.22B
Dec. 31, 2012 55.70B
Sept. 30, 2012 53.72B
June 30, 2012 57.38B
March 31, 2012 59.90B
Dec. 31, 2011 61.51B
Sept. 30, 2011 65.06B
June 30, 2011 64.44B
March 31, 2011 65.09B
Dec. 31, 2010 65.16B
Sept. 30, 2010 66.24B
June 30, 2010 61.87B
March 31, 2010 55.72B
Dec. 31, 2009 50.01B
Sept. 30, 2009 45.82B
June 30, 2009 46.17B
March 31, 2009 47.32B
Dec. 31, 2008 48.30B
Sept. 30, 2008 48.82B
June 30, 2008 48.84B
March 31, 2008 47.79B
Dec. 31, 2007 48.42B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Benchmarks

Benchmarks
Amgen Inc 23.97B
Biogen Inc 14.42B
Gilead Sciences Inc 22.72B

Revenue (TTM) Range, Past 5 Years

Minimum 47.92B Sep 2015
Maximum 53.86B Mar 2019
Average 52.01B
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.